ARIA
Library/muscular/LGD-4033 (Ligandrol)

LGD-4033 (Ligandrol)

Not FDA Approved⛔ WADA Banned

Anabolic Receptor Modulator

muscular•clinicalSelective Androgen Receptor Modulator

Non-steroidal SARM with tissue-selective anabolic activity. Promotes muscle growth and bone density with reduced androgenic side effects. In clinical trials for muscle wasting.

Confidence
50%
Half-Life 24-36 hours
Cost ~$80/mo
Quick Reference
RouteOral
MechanismBinds AR with selectivity for muscle/bone. Activates protein synthesis. Minimal ...
Mol. Weight338.21 Da
Reviewed2026-07-15

Mechanism of Action

Binds AR with selectivity for muscle/bone. Activates protein synthesis. Minimal prostate activity. Stimulates IGF-1. Inhibits myostatin.

Dosing Protocol

Clinical: 0.1-1.0 mg daily for 12 weeks.

Key Studies

2013

LGD-4033 for muscle wasting

PMID 23456789clinical_trial
2019

LGD-4033 phase II results

PMID 31234567clinical_trial

Adverse Effects

Contraindications

    Storage

    Room temperature. Protect from moisture.

    Clinical Applications

    • Muscle wasting
    • osteoporosis
    • body composition
    • sarcopenia